Jan Oscarsson

Also affiliated with AstraZeneca (Sweden), AstraZeneca (Spain)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Sodium-Glucose Cotransporter Inhibition Preserves Apolipoprotein M During Acute Inflammation in Mice and Humans”.

Sodium-Glucose Cotransporter Inhibition Preserves Apolipoprotein M During Acute Inflammation in Mice and Humans

JACC Advances(2025)10.1016/j.jacadv.2025.101839

N/A

0.241DataRank · unranked

4 citations

Aynaz Lotfinaghsh, Zhen Guo, Tripti Kumari, Kana N. Miyata, Alireza Sargazi +27 more

A role for sodium glucose cotransporter 2 inhibitors (SGLT2is) in the treatment of Alzheimer's disease?

International review of neurobiology(2020)10.1016/bs.irn.2020.03.018

N/A

0DataRank · unranked

50 citations

Jan Oscarsson, Jeffrey M. Burns, Russell Esterline

13 C tracing in synaptosomes reveals that SGLT2 inhibition with dapagliflozin prevents metabolic deficits in the 5X-FAD model of Alzheimer’s Disease

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.04.30.651373

N/A

0DataRank · unranked

1 citations

Cansheng Zhu, Bezawit T. Danna, Xiaohong Zuo, Amy Rios, Krista Yang +13 more

Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trial

Cardiovascular Diabetology(2025)10.1186/s12933-025-02875-6

N/A

0DataRank · unranked

0 citations

Remo H.M. Furtado, Russell Esterline, Jan Oscarsson, Samvel B. Gasparyan, Gary G. Koch +18 more